The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Powder Hemostatic Agent Market Research Report 2025
Synopsis
A powdered medicament that can stop bleeding when the body bleeds
The global Powder Hemostatic Agent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Powder Hemostatic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Powder Hemostatic Agent.
Report Scope
The Powder Hemostatic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Powder Hemostatic Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Powder Hemostatic Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson（Ethicon）
Celox Medical
Amed Therapeutics
Cryolife
BioCer Entwicklungs-GmbH
Yunnan Baiyao
HHAO TECHNOLOGY
Segment by Type
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent
Segment by Application
Hospitals
Clinics
Home Care
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Powder Hemostatic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Powder Hemostatic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A powdered medicament that can stop bleeding when the body bleeds
The global Powder Hemostatic Agent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Powder Hemostatic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Powder Hemostatic Agent.
Report Scope
The Powder Hemostatic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Powder Hemostatic Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Powder Hemostatic Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson（Ethicon）
Celox Medical
Amed Therapeutics
Cryolife
BioCer Entwicklungs-GmbH
Yunnan Baiyao
HHAO TECHNOLOGY
Segment by Type
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent
Segment by Application
Hospitals
Clinics
Home Care
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Powder Hemostatic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Powder Hemostatic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Powder Hemostatic Agent Market Overview
1.1 Product Overview and Scope of Powder Hemostatic Agent
1.2 Powder Hemostatic Agent Segment by Type
1.2.1 Global Powder Hemostatic Agent Market Value Comparison by Type (2024-2030)
1.2.2 Absorbable Hemostatic Agent
1.2.3 Not Absorbable Hemostatic Agent
1.3 Powder Hemostatic Agent Segment by Application
1.3.1 Global Powder Hemostatic Agent Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Powder Hemostatic Agent Market Size Estimates and Forecasts
1.4.1 Global Powder Hemostatic Agent Revenue 2019-2030
1.4.2 Global Powder Hemostatic Agent Sales 2019-2030
1.4.3 Global Powder Hemostatic Agent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Powder Hemostatic Agent Market Competition by Manufacturers
2.1 Global Powder Hemostatic Agent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Powder Hemostatic Agent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Powder Hemostatic Agent Average Price by Manufacturers (2019-2024)
2.4 Global Powder Hemostatic Agent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Powder Hemostatic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Powder Hemostatic Agent, Product Type & Application
2.7 Powder Hemostatic Agent Market Competitive Situation and Trends
2.7.1 Powder Hemostatic Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Powder Hemostatic Agent Players Market Share by Revenue
2.7.3 Global Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Powder Hemostatic Agent Retrospective Market Scenario by Region
3.1 Global Powder Hemostatic Agent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Powder Hemostatic Agent Global Powder Hemostatic Agent Sales by Region: 2019-2030
3.2.1 Global Powder Hemostatic Agent Sales by Region: 2019-2024
3.2.2 Global Powder Hemostatic Agent Sales by Region: 2025-2030
3.3 Global Powder Hemostatic Agent Global Powder Hemostatic Agent Revenue by Region: 2019-2030
3.3.1 Global Powder Hemostatic Agent Revenue by Region: 2019-2024
3.3.2 Global Powder Hemostatic Agent Revenue by Region: 2025-2030
3.4 North America Powder Hemostatic Agent Market Facts & Figures by Country
3.4.1 North America Powder Hemostatic Agent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Powder Hemostatic Agent Sales by Country (2019-2030)
3.4.3 North America Powder Hemostatic Agent Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Powder Hemostatic Agent Market Facts & Figures by Country
3.5.1 Europe Powder Hemostatic Agent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Powder Hemostatic Agent Sales by Country (2019-2030)
3.5.3 Europe Powder Hemostatic Agent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Powder Hemostatic Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Powder Hemostatic Agent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Powder Hemostatic Agent Sales by Country (2019-2030)
3.6.3 Asia Pacific Powder Hemostatic Agent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Powder Hemostatic Agent Market Facts & Figures by Country
3.7.1 Latin America Powder Hemostatic Agent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Powder Hemostatic Agent Sales by Country (2019-2030)
3.7.3 Latin America Powder Hemostatic Agent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Powder Hemostatic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Powder Hemostatic Agent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Powder Hemostatic Agent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Powder Hemostatic Agent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Powder Hemostatic Agent Sales by Type (2019-2030)
4.1.1 Global Powder Hemostatic Agent Sales by Type (2019-2024)
4.1.2 Global Powder Hemostatic Agent Sales by Type (2025-2030)
4.1.3 Global Powder Hemostatic Agent Sales Market Share by Type (2019-2030)
4.2 Global Powder Hemostatic Agent Revenue by Type (2019-2030)
4.2.1 Global Powder Hemostatic Agent Revenue by Type (2019-2024)
4.2.2 Global Powder Hemostatic Agent Revenue by Type (2025-2030)
4.2.3 Global Powder Hemostatic Agent Revenue Market Share by Type (2019-2030)
4.3 Global Powder Hemostatic Agent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Powder Hemostatic Agent Sales by Application (2019-2030)
5.1.1 Global Powder Hemostatic Agent Sales by Application (2019-2024)
5.1.2 Global Powder Hemostatic Agent Sales by Application (2025-2030)
5.1.3 Global Powder Hemostatic Agent Sales Market Share by Application (2019-2030)
5.2 Global Powder Hemostatic Agent Revenue by Application (2019-2030)
5.2.1 Global Powder Hemostatic Agent Revenue by Application (2019-2024)
5.2.2 Global Powder Hemostatic Agent Revenue by Application (2025-2030)
5.2.3 Global Powder Hemostatic Agent Revenue Market Share by Application (2019-2030)
5.3 Global Powder Hemostatic Agent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson（Ethicon）
6.1.1 Johnson & Johnson（Ethicon） Corporation Information
6.1.2 Johnson & Johnson（Ethicon） Description and Business Overview
6.1.3 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Product Portfolio
6.1.5 Johnson & Johnson（Ethicon） Recent Developments/Updates
6.2 Celox Medical
6.2.1 Celox Medical Corporation Information
6.2.2 Celox Medical Description and Business Overview
6.2.3 Celox Medical Powder Hemostatic Agent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Celox Medical Powder Hemostatic Agent Product Portfolio
6.2.5 Celox Medical Recent Developments/Updates
6.3 Amed Therapeutics
6.3.1 Amed Therapeutics Corporation Information
6.3.2 Amed Therapeutics Description and Business Overview
6.3.3 Amed Therapeutics Powder Hemostatic Agent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amed Therapeutics Powder Hemostatic Agent Product Portfolio
6.3.5 Amed Therapeutics Recent Developments/Updates
6.4 Cryolife
6.4.1 Cryolife Corporation Information
6.4.2 Cryolife Description and Business Overview
6.4.3 Cryolife Powder Hemostatic Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cryolife Powder Hemostatic Agent Product Portfolio
6.4.5 Cryolife Recent Developments/Updates
6.5 BioCer Entwicklungs-GmbH
6.5.1 BioCer Entwicklungs-GmbH Corporation Information
6.5.2 BioCer Entwicklungs-GmbH Description and Business Overview
6.5.3 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product Portfolio
6.5.5 BioCer Entwicklungs-GmbH Recent Developments/Updates
6.6 Yunnan Baiyao
6.6.1 Yunnan Baiyao Corporation Information
6.6.2 Yunnan Baiyao Description and Business Overview
6.6.3 Yunnan Baiyao Powder Hemostatic Agent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Yunnan Baiyao Powder Hemostatic Agent Product Portfolio
6.6.5 Yunnan Baiyao Recent Developments/Updates
6.7 HHAO TECHNOLOGY
6.6.1 HHAO TECHNOLOGY Corporation Information
6.6.2 HHAO TECHNOLOGY Description and Business Overview
6.6.3 HHAO TECHNOLOGY Powder Hemostatic Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HHAO TECHNOLOGY Powder Hemostatic Agent Product Portfolio
6.7.5 HHAO TECHNOLOGY Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Powder Hemostatic Agent Industry Chain Analysis
7.2 Powder Hemostatic Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Powder Hemostatic Agent Production Mode & Process
7.4 Powder Hemostatic Agent Sales and Marketing
7.4.1 Powder Hemostatic Agent Sales Channels
7.4.2 Powder Hemostatic Agent Distributors
7.5 Powder Hemostatic Agent Customers
8 Powder Hemostatic Agent Market Dynamics
8.1 Powder Hemostatic Agent Industry Trends
8.2 Powder Hemostatic Agent Market Drivers
8.3 Powder Hemostatic Agent Market Challenges
8.4 Powder Hemostatic Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Powder Hemostatic Agent Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Powder Hemostatic Agent Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Powder Hemostatic Agent Market Competitive Situation by Manufacturers in 2023
Table 4. Global Powder Hemostatic Agent Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Powder Hemostatic Agent Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Powder Hemostatic Agent Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Powder Hemostatic Agent Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Powder Hemostatic Agent Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Powder Hemostatic Agent, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Powder Hemostatic Agent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Powder Hemostatic Agent, Product Type & Application
Table 12. Global Key Manufacturers of Powder Hemostatic Agent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Powder Hemostatic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Powder Hemostatic Agent as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Powder Hemostatic Agent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Powder Hemostatic Agent Sales by Region (2019-2024) & (K Units)
Table 18. Global Powder Hemostatic Agent Sales Market Share by Region (2019-2024)
Table 19. Global Powder Hemostatic Agent Sales by Region (2025-2030) & (K Units)
Table 20. Global Powder Hemostatic Agent Sales Market Share by Region (2025-2030)
Table 21. Global Powder Hemostatic Agent Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Powder Hemostatic Agent Revenue Market Share by Region (2019-2024)
Table 23. Global Powder Hemostatic Agent Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Powder Hemostatic Agent Revenue Market Share by Region (2025-2030)
Table 25. North America Powder Hemostatic Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Powder Hemostatic Agent Sales by Country (2019-2024) & (K Units)
Table 27. North America Powder Hemostatic Agent Sales by Country (2025-2030) & (K Units)
Table 28. North America Powder Hemostatic Agent Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Powder Hemostatic Agent Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Powder Hemostatic Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Powder Hemostatic Agent Sales by Country (2019-2024) & (K Units)
Table 32. Europe Powder Hemostatic Agent Sales by Country (2025-2030) & (K Units)
Table 33. Europe Powder Hemostatic Agent Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Powder Hemostatic Agent Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Powder Hemostatic Agent Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Powder Hemostatic Agent Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Powder Hemostatic Agent Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Powder Hemostatic Agent Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Powder Hemostatic Agent Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Powder Hemostatic Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Powder Hemostatic Agent Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Powder Hemostatic Agent Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Powder Hemostatic Agent Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Powder Hemostatic Agent Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Powder Hemostatic Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Powder Hemostatic Agent Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Powder Hemostatic Agent Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Powder Hemostatic Agent Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Powder Hemostatic Agent Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Powder Hemostatic Agent Sales (K Units) by Type (2019-2024)
Table 51. Global Powder Hemostatic Agent Sales (K Units) by Type (2025-2030)
Table 52. Global Powder Hemostatic Agent Sales Market Share by Type (2019-2024)
Table 53. Global Powder Hemostatic Agent Sales Market Share by Type (2025-2030)
Table 54. Global Powder Hemostatic Agent Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Powder Hemostatic Agent Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Powder Hemostatic Agent Revenue Market Share by Type (2019-2024)
Table 57. Global Powder Hemostatic Agent Revenue Market Share by Type (2025-2030)
Table 58. Global Powder Hemostatic Agent Price (USD/Unit) by Type (2019-2024)
Table 59. Global Powder Hemostatic Agent Price (USD/Unit) by Type (2025-2030)
Table 60. Global Powder Hemostatic Agent Sales (K Units) by Application (2019-2024)
Table 61. Global Powder Hemostatic Agent Sales (K Units) by Application (2025-2030)
Table 62. Global Powder Hemostatic Agent Sales Market Share by Application (2019-2024)
Table 63. Global Powder Hemostatic Agent Sales Market Share by Application (2025-2030)
Table 64. Global Powder Hemostatic Agent Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Powder Hemostatic Agent Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Powder Hemostatic Agent Revenue Market Share by Application (2019-2024)
Table 67. Global Powder Hemostatic Agent Revenue Market Share by Application (2025-2030)
Table 68. Global Powder Hemostatic Agent Price (USD/Unit) by Application (2019-2024)
Table 69. Global Powder Hemostatic Agent Price (USD/Unit) by Application (2025-2030)
Table 70. Johnson & Johnson（Ethicon） Corporation Information
Table 71. Johnson & Johnson（Ethicon） Description and Business Overview
Table 72. Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson（Ethicon） Powder Hemostatic Agent Product
Table 74. Johnson & Johnson（Ethicon） Recent Developments/Updates
Table 75. Celox Medical Corporation Information
Table 76. Celox Medical Description and Business Overview
Table 77. Celox Medical Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Celox Medical Powder Hemostatic Agent Product
Table 79. Celox Medical Recent Developments/Updates
Table 80. Amed Therapeutics Corporation Information
Table 81. Amed Therapeutics Description and Business Overview
Table 82. Amed Therapeutics Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Amed Therapeutics Powder Hemostatic Agent Product
Table 84. Amed Therapeutics Recent Developments/Updates
Table 85. Cryolife Corporation Information
Table 86. Cryolife Description and Business Overview
Table 87. Cryolife Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Cryolife Powder Hemostatic Agent Product
Table 89. Cryolife Recent Developments/Updates
Table 90. BioCer Entwicklungs-GmbH Corporation Information
Table 91. BioCer Entwicklungs-GmbH Description and Business Overview
Table 92. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product
Table 94. BioCer Entwicklungs-GmbH Recent Developments/Updates
Table 95. Yunnan Baiyao Corporation Information
Table 96. Yunnan Baiyao Description and Business Overview
Table 97. Yunnan Baiyao Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Yunnan Baiyao Powder Hemostatic Agent Product
Table 99. Yunnan Baiyao Recent Developments/Updates
Table 100. HHAO TECHNOLOGY Corporation Information
Table 101. HHAO TECHNOLOGY Description and Business Overview
Table 102. HHAO TECHNOLOGY Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. HHAO TECHNOLOGY Powder Hemostatic Agent Product
Table 104. HHAO TECHNOLOGY Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Powder Hemostatic Agent Distributors List
Table 108. Powder Hemostatic Agent Customers List
Table 109. Powder Hemostatic Agent Market Trends
Table 110. Powder Hemostatic Agent Market Drivers
Table 111. Powder Hemostatic Agent Market Challenges
Table 112. Powder Hemostatic Agent Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Powder Hemostatic Agent
Figure 2. Global Powder Hemostatic Agent Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Powder Hemostatic Agent Market Share by Type in 2023 & 2030
Figure 4. Absorbable Hemostatic Agent Product Picture
Figure 5. Not Absorbable Hemostatic Agent Product Picture
Figure 6. Global Powder Hemostatic Agent Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Powder Hemostatic Agent Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Home Care
Figure 11. Global Powder Hemostatic Agent Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Powder Hemostatic Agent Market Size (2019-2030) & (US$ Million)
Figure 13. Global Powder Hemostatic Agent Sales (2019-2030) & (K Units)
Figure 14. Global Powder Hemostatic Agent Average Price (USD/Unit) & (2019-2030)
Figure 15. Powder Hemostatic Agent Report Years Considered
Figure 16. Powder Hemostatic Agent Sales Share by Manufacturers in 2023
Figure 17. Global Powder Hemostatic Agent Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Powder Hemostatic Agent Players: Market Share by Revenue in 2023
Figure 19. Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Powder Hemostatic Agent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Powder Hemostatic Agent Sales Market Share by Country (2019-2030)
Figure 22. North America Powder Hemostatic Agent Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Powder Hemostatic Agent Sales Market Share by Country (2019-2030)
Figure 26. Europe Powder Hemostatic Agent Revenue Market Share by Country (2019-2030)
Figure 27. Germany Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Powder Hemostatic Agent Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Powder Hemostatic Agent Revenue Market Share by Region (2019-2030)
Figure 34. China Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Powder Hemostatic Agent Sales Market Share by Country (2019-2030)
Figure 45. Latin America Powder Hemostatic Agent Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Powder Hemostatic Agent Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Powder Hemostatic Agent Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Powder Hemostatic Agent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Powder Hemostatic Agent by Type (2019-2030)
Figure 55. Global Revenue Market Share of Powder Hemostatic Agent by Type (2019-2030)
Figure 56. Global Powder Hemostatic Agent Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Powder Hemostatic Agent by Application (2019-2030)
Figure 58. Global Revenue Market Share of Powder Hemostatic Agent by Application (2019-2030)
Figure 59. Global Powder Hemostatic Agent Price (USD/Unit) by Application (2019-2030)
Figure 60. Powder Hemostatic Agent Value Chain
Figure 61. Powder Hemostatic Agent Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
